Related Experiment Videos
Ultrastructural studies of the hepatic changes brought about by Clindamycin and Erythromycin in animals
Toxicology and Applied Pharmacology
|June 1, 1971
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A microfluidic sucrose gap device for electrical measurement of gap junction connectivity.
The Review of scientific instruments·2025
Accuracy of Dental Implant Placement using Robotics. A Systematic Review of in vitro Studies.
The European journal of prosthodontics and restorative dentistry·2024
Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis.
Multiple sclerosis and related disorders·2022
Managing an adult CF population in the COVID-19 pandemic-1 year on.
QJM : monthly journal of the Association of Physicians·2021
Acute or developmental exposure of primary rat cortical cells to Emamectin Benzoate disrupts gene expression.
Toxicology and applied pharmacology·2026
Increased chromatin accessibility following 1α,25-dihydroxyvitamin D3 treatment in human endometrial stromal cells.
Toxicology and applied pharmacology·2026
MRP4 deficiency exacerbates diet-induced MASLD through dysregulation of hepatic lipid handling.
Toxicology and applied pharmacology·2026
Impact of chronic oral aflatoxin B1 exposure on iron metabolism in a pig model.
Toxicology and applied pharmacology·2026
Reprogramming NAD+ homeostasis and FOXO3a-Nrf2 signaling mitigates bleomycin-driven pulmonary fibrosis.
Toxicology and applied pharmacology·2026
Chronic inhalation of m-xylene disrupts vascular homeostasis through endothelial injury and impaired vascular repair.
Toxicology and applied pharmacology·2026
Navigating clozapine discontinuation in clinical practice: An updated framework.
Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Early intervention with clozapine: Is there a neurobiological critical period for treatment-resistant schizophrenia?
Journal of psychopharmacology (Oxford, England)·2026